跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Augmentin Es - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Augmentin Es
Approved
STANDARD
Augmentin Es
Glaxo Wellcome Production -Mayenne
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
880eca15209c3b60
Company
Glaxo Wellcome Production -Mayenne
Type
Standard
Approval Details
Approval Id
880eca15209c3b60
Drug Approval Philippines Name
Augmentin Es
Product Name
Augmentin Es
Registration Number
DR-XY32295
Brand Name
Augmentin Es
Generic Name
Co-Amoxiclav
Dosage Form
Powder For Suspension
Dosage Strength
600 mg/42.9 mg per 5 mL
Manufacturer
Glaxo Wellcome Production -Mayenne
Importer
GlaxoSmithKline Philippines, Inc.
Issuance Date
27 July 2023
Expiry Date
02 September 2028
Pharmacologic Category
Antibacterial (Penicillin)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
880eca15209c3b60
Type
Standard
Back to Philippines FDA Approvals